Immune tolerance

Stem cells from cord blood are being investigated as a possible to assist patient recovery following organ transplantation. Click on the link provided to find out more about the trial. It remains too early to know if the approach will be suitable. We need evidence collected in clinical trials to determine if a proposed stem cell treatment is both safe and effective.

tagged as Immune tolerance

  • Human Mesenchymal Stem Cells Induce Liver Transplant Tolerance Location: China
    Overview: This trial aims to determine the benefit of using mesenchymal stem cells obtained from donated umbilical cord blood as an immunosuppressive agent in liver transplant patients. The trial is being conducted at the Beijing 302 PLA Hospital and expects to recruit 50 subjects by February 2015. Participants in the trial will receive either standard immunosuppression treatment following their liver transplant (control group); or they will weekly injections of mesenchymal stem cells for 12 weeks, in addition to the standard immunosuppression treatment (experimental group). Participants will be monitored for complications and for changes in liver function tests.
    Link to Clinical Registry
    Trial Design: Safety and Efficacy Study
    Status: Open - Recruiting
    Stem Cell: Umbilical Cord Stem Cells